Status:
UNKNOWN
Evaluation of Transperineal US in Stress Incontinence
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Kasr El Aini Hospital
Conditions:
Stress Incontinence, Female
Eligibility:
FEMALE
20-75 years
Brief Summary
Stress urinary incontinence (SUI) has an observed prevalence of between 4%and 35%.Identified risk factors are aging, obesity and repeated pregnancies and deliveries. Urodynamic remains the gold stand...
Detailed Description
A comparative observational cross sectional study will be conducted . The symptom, or "subjective indicator of disease," of SUI is described as "the complaint of involuntary leakage on effort or exer...
Eligibility Criteria
Inclusion
- females between 20-75 years old
- -Women diagnosed to have genuine stress urinary incontinence diagnosed by history taking, voiding diary and confirmed by urodynamic.
Exclusion
- -Known to be Diabetic
- Urge incontinence or mixed type
- Voiding dysfunction
- Neurological problems
- open suprapubic wound
- Previous surgery for POP(pelvic organ prolapse) or incontinence
- suspicion of pelvic malignancy
Key Trial Info
Start Date :
January 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 8 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03397368
Start Date
January 16 2018
End Date
December 8 2019
Last Update
August 6 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasralainy Hospital
Cairo, Egypt
2
Algazeerah
Giza, Egypt